Covance Inc. (CVD) said it entered into a biomarker alliance and services agreement with Rules-Based Medicine, Inc., or RBM.
Subject to the terms of the agreement, Covance will use RBM as its exclusive third-party provider of multiplexed protein biomarker testing services, and RBM will use Covance as its exclusive referral source for laboratory testing services.
For comments and feedback: editorial@rttnews.com